Combination of ASA with dabigatran or rivaroxaban increases risk of bleeding without additional benefit of stroke reduction in patients with atrial fibrillation

• Published in: Journal of the American College of Cardiology
• Main Authors: Strunets, Anton, Mirza, Mahek, Cho, Chris C, Sra, Jasbir, Jahangir, Arshad
• Format: Text
• Language: unknown
• Published: Advocate Aurora Health Institutional Repository 2014
• Subjects: novel oral anticoagulants; warfarin; aspirin; ASA; dabigatran; rivaroxaban; bleeding; atrial fibrillation; stroke; risk; Advocate Aurora Research Institute; Cardiology; Aurora Research Institute
• Online Access: https://institutionalrepository.aah.org/pharm/5; https://doi.org/10.1016/S0735-1097(14)60440-X